Gregory C. Critchfield, President Myriad Genetic Labs at MYRIAD GENETICS INC (MYGN), sold 24,615 shares at $74.50 ($1.5M) on 2009-01-28, disclosed to the SEC on 2009-01-30.
Scheduled sale ($1.5M) by President Myriad Genetic Labs under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 4,615 | $0 | 0.0% |
| 2 | $74.50 | 20,000 | $1.5M | 100.0% |
| Total | $60.53 avg | 24,615 | $1.5M | 100% |
| Filing → |
| MYGN | SELL | 2008-09-17 | $2.1M | — | Filing → |
| MYGN | SELL | 2007-09-27 | $1.4M | — | Filing → |
| MYGN | SELL | 2006-04-17 | $873K | — | Filing → |